Mostrando postagens com marcador Biomedical engineering. Mostrar todas as postagens
Mostrando postagens com marcador Biomedical engineering. Mostrar todas as postagens

quarta-feira, 2 de setembro de 2015

Robotic step training, noninvasive spinal stimulation enable patient to take thousands of steps

 

 

Mark Pollock and trainer Simon O’Donnell.

Credit: Courtesy of Mark Pollock

A 39-year-old man who had had been completely paralyzed for four years was able to voluntarily control his leg muscles and take thousands of steps in a "robotic exoskeleton" device during five days of training -- and for two weeks afterward -- a team of UCLA scientists reports this week.

This is the first time that a person with chronic, complete paralysis has regained enough voluntary control to actively work with a robotic device designed to enhance mobility.

In addition to the robotic device, the man was aided by a novel noninvasive spinal stimulation technique that does not require surgery. His leg movements also resulted in other health benefits, including improved cardiovascular function and muscle tone.

The new approach combines a battery-powered wearable bionic suit that enables people to move their legs in a step-like fashion, with a noninvasive procedure that the same researchers had previously used to enable five men who had been completely paralyzed to move their legs in a rhythmic motion. That earlier achievement is believed to be the first time people who are completely paralyzed have been able to relearn voluntary leg movements without surgery. (The researchers do not describe the achievement as "walking" because no one who is completely paralyzed has independently walked in the absence of the robotic device and electrical stimulation of the spinal cord.)

In the latest study, the researchers treated Mark Pollock, who lost his sight in 1998 and later became the first blind man to race to the South Pole. In 2010, Pollock fell from a second-story window and suffered a spinal cord injury that left him paralyzed from the waist down.

At UCLA, Pollock made substantial progress after receiving a few weeks of physical training without spinal stimulation and then just five days of spinal stimulation training in a one-week span, for about an hour a day.

"In the last few weeks of the trial, my heart rate hit 138 beats per minute," Pollock said. "This is an aerobic training zone, a rate I haven't even come close to since being paralyzed while walking in the robot alone, without these interventions. That was a very exciting, emotional moment for me, having spent my whole adult life before breaking my back as an athlete."

Even in the years since he lost his sight, Pollock has competed in ultra-endurance races across deserts, mountains and the polar ice caps. He also won silver and bronze medals in rowing at the Commonwealth Games and launched a motivational speaking business.

"Stepping with the stimulation and having my heart rate increase, along with the awareness of my legs under me, was addictive. I wanted more," he said.

The research will be published by the IEEE Engineering in Medicine and Biology Society, the world's largest society of biomedical engineers.

"It will be difficult to get people with complete paralysis to walk completely independently, but even if they don't accomplish that, the fact they can assist themselves in walking will greatly improve their overall health and quality of life," said V. Reggie Edgerton, senior author of the research and a UCLA distinguished professor of integrative biology and physiology, neurobiology and neurosurgery.

The procedure used a robotic device manufactured by Richmond, California-based Ekso Bionics which captures data that enables the research team to determine how much the subject is moving his own limbs, as opposed to being aided by the device.

"If the robot does all the work, the subject becomes passive and the nervous system shuts down," Edgerton said.

The data showed that Pollock was actively flexing his left knee and raising his left leg and that during and after the electrical stimulation, he was able to voluntarily assist the robot during stepping; it wasn't just the robotic device doing the work.

"For people who are severely injured but not completely paralyzed, there's every reason to believe that they will have the opportunity to use these types of interventions to further improve their level of function. They're likely to improve even more," Edgerton said. "We need to expand the clinical toolbox available for people with spinal cord injury and other diseases."

Edgerton and his research team have received many awards and honors for their research, including Popular Mechanics' 2011 Breakthrough Award.

"Dr. Edgerton is a pioneer and we are encouraged by these findings to broaden our understanding of possible treatment options for paralysis," said Peter Wilderotter, president and CEO of the Christopher and Dana Reeve Foundation, which helped fund the research. "Given the complexities of a spinal cord injury, there will be no one-size-fits-all cure but rather a combination of different interventions to achieve functional recovery.

"What we are seeing right now in the field of spinal cord research is a surge of momentum with new directions and approaches to remind the spine of its potential even years after an injury," he said.

Grace Peng, director of NIBIB's Rehabilitation Engineering Program, said, "This is a great example of a therapeutic approach that combines two very different modalities -- neuromodulation and robotic assist devices -- to achieve a result that could not be realized with either approach alone. This multi-device approach, much like multi-drug therapy, may ultimately benefit patients with impaired mobility in a wide variety of rehabilitation settings."

NeuroRecovery Technologies, a medical technology company Edgerton founded, designs and develops devices that help restore movement in patients with paralysis. The company provided the device used to stimulate the spinal cord in combination with the Ekso in this research.

Edgerton said although it likely will be years before the new approaches are widely available, he now believes it is possible to significantly improve quality of life for patients with severe spinal cord injuries, and to help them recover multiple body functions. Although his laboratory is making dramatic progress, it only is able to work with a small number of patients due to limited resources.

"We could accomplish a lot more in advancing the science and technology with more resources," Edgerton said.

More information can be found at: http://emb.citengine.com/event/embc-2015/paper-details?pdID=4403

University of California - Los Angeles. "Completely paralyzed man voluntarily moves his legs, scientists report: Robotic step training, noninvasive spinal stimulation enable patient to take thousands of steps." ScienceDaily. ScienceDaily, 1 September 2015. <www.sciencedaily.com/releases/2015/09/150901204831.htm>.

sexta-feira, 10 de outubro de 2014

New technique yields fast results in drug, biomedical testing

 


A new technique makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine, representing a potential tool for clinicians and law enforcement.

The technique works by extracting minute quantities of target molecules contained in specimens of blood, urine or other biological fluids, and then testing the sample with a mass spectrometer.

Testing carried out with the technology takes minutes, whereas conventional laboratory methods take hours or days to yield results and require a complex sequence of steps, said Zheng Ouyang (pronounced Jung O-Yong), an associate professor in Purdue University's Weldon School of Biomedical Engineering.

"We've converted a series of operations into a single extraction process requiring only a pinprick's worth of blood," he said.

The method, called "slug flow microextraction," could be used to detect steroids in urine for drug screening in professional sports and might be combined with a miniature mass spectrometer also being commercialized. The combined technologies could bring a new class of compact instruments for medicine and research, Ouyang said.

Findings are detailed in a paper appeared online Oct. 5 in the research journal Angewandte Chemie International Edition. The paper was authored by graduate student Yue Ren, undergraduate student Morgan N. McLuckey, former postdoctoral research associate Jiangjiang Liu and Ouyang.

The researchers demonstrated the technique, using it to perform therapeutic-drug monitoring, which has potential applications in drug development and personalized therapy; to monitor enzyme function, as demonstrated for acetylcholinesterase, which is directly related to the symptoms and therapy for Alzheimer's disease; to detect steroids, yielding results in one minute; and to test for illicit drugs.

"In the future, for example, parents might be able to test their children's urine for drugs with a simple cartridge they would take to the corner drug store, where a desktop mass spectrometer would provide results in a few minutes," Ouyang said.

The technique involves drawing a specimen into a glass capillary that also contains the organic solvent ethyl acetate.

Like oil and water, the two fluids are immiscible, and an interface is formed between the specimen and the solvent. Gently rocking the capillary back and forth several times causes small amounts of target molecules in the biological sample to cross this interface into the solvent side without mixing the two fluids.

"You don't want to mix these two, you want to extract only the biomarkers you are looking for and leave the junk behind because mass spectrometry is very sensitive to impurities," Ouyang said.

Then the solvent containing the biomarkers is subjected to a high-voltage current, ionizing the sample so that it can be analyzed with mass spectrometry.

Researchers have used microextraction for other applications.

"I think this is the first time it has been applied to a biological sample for mass spectrometry," Ouyang said. "You just use a pinprick of blood, and the analysis is completed in minutes."

When combined with the miniature mass spectrometer also developed at Purdue the method represents a mobile system for medical professionals, researchers and law enforcement.

Mass spectrometry works by turning molecules into ions, or electrically charged versions of themselves, inside the instrument's vacuum chamber. Once ionized, the molecules can be more easily manipulated, detected and analyzed based on their masses. The new approach uses a method called nanoESI -- or nano electrospray ionization -- in which the ionization step is performed in the air or directly on surfaces and does not require a vacuum chamber.

Although the research was conducted using a conventional laboratory mass spectrometer, the same nanoESI operation could be carried out with the new miniature mass spectrometer. Whereas conventional mass spectrometers are bulky instruments that weigh more than 300 pounds, Purdue researchers have recently completed their latest version of the miniature mass spectrometer, the Mini 12, which weighs 40 pounds, is 12.5 inches wide and 16 inches high.

"The sampling ionization technologies like slug flow microextraction could make the miniature mass spectrometers perform the actual testing without requiring other equipment for sample treatment," Ouyang said. "This will bring a new class of compact medical instruments."

The research has been funded by the National Institutes of Health.

The work to develop the miniature mass spectrometer has been supported by the NIH and National Science Foundation and is led by Ouyang and R. Graham Cooks, the Henry Bohn Hass Distinguished Professor of Chemistry in Purdue's College of Science.

U.S. patent applications have been filed for the microextraction and miniature mass spectrometry. The technologies may be commercialized through a new company formed after partnership agreements were signed in 2013 by Purdue and Tsinghua University.

"The overall goal is to use this technology for developing disposable sample cartridges to work with our mini mass spectrometry system in clinical and especially the point-of-care applications in a doctor's office," Ouyang said.


Story Source:

The above story is based on materials provided by Purdue University. The original article was written by Emil Venere. Note: Materials may be edited for content and length.


Journal Reference:

  1. Yue Ren, Morgan N. McLuckey, Jiangjiang Liu, Zheng Ouyang. Direct Mass Spectrometry Analysis of Biofluid Samples Using Slug-Flow Microextraction Nano-Electrospray Ionization. Angewandte Chemie International Edition, 2014; DOI: 10.1002/anie.201408338